Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Pharm. 2013 Nov 18;456(2):536-44. doi: 10.1016/j.ijpharm.2013.08.016. Epub 2013 Aug 24.

Intra-articular fate of degradable poly(ethyleneglycol)-hydrogel microspheres as carriers for sustained drug delivery.

Author information

1
Occlugel, Archimed, 12 rue Charles de Gaulle, 78350 Jouy en Josas, France.

Abstract

A novel degradable microsphere (MS) for intra-articular drug delivery, composed of a polyethylene glycol (PEG) core containing degradable regions made of short poly-(lactic-co-glycolic acid) (PLGA) sequences - named PEG-hydrogel MS - was injected into the cavity of sheep shoulder joint, and compared to non-degradable MS devoid of hydrolysable crosslinker in terms of location, degradation and inflammation. One week after intra-articular injection both groups of MS were localized beneath the synovial lining of the synovial fringes located at bottom of the shoulder joint, while a fraction of particles remained in synovial fluid. Histological analyses made one and 4 weeks after intra-articular injection showed cell proliferation around the non-degradable MS entrapped within the synovium. By contrast, degradable PEG-hydrogel MS were surrounded by few cells. The degradation of degradable PEG-hydrogel MS within the synovium was slow and was not fully complete after four weeks. Our findings indicate that the tissue entrapment of MS below the synovial lining was independent of the material degradability, while degradable PEG-hydrogel MS are less inflammatory than the non-degradable one. Degradable PEG-hydrogel MS offer several advantages over the non-degradable MS as carriers for a sustained drug delivery in synovial tissue according to the low intensity of inflammatory reaction triggered in synovium.

KEYWORDS:

DDD-MS; DDS; Drug delivery; Hydrogel; IA; IA-DDS; Intra-articular; Microspheres; Osteoarthritis; degradable drug delivery system; drug delivery system; intra-articular; intra-articular drug delivery system

PMID:
23978631
DOI:
10.1016/j.ijpharm.2013.08.016
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center